Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
read more
https://www.chimeron.com/wp-content/uploads/2023/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
750
750
Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio | Advancing Genetic Medicine
https://www.chimeron.com/wp-content/uploads/2023/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
Our Vision
Chimeron Bio is redefining genetic medicine with future-forward RNA technology designed to deliver meaningful results for patients.
How we do it
Chimeron Bio's unique multiplex particle & delivery platform leverage chimera encased self-amplifying RNA to achieve superior expression and broader dynamic range compared to other leading RNA technologies.
Large Payloads
Can carry large RNA payloads, combined with self-amplification to deliver larger proteins or multiple proteins
Multiple Gene Delivery
Delivery of RNA expressing multiple different proteins
Targeted Uptake
Potential for targeted delivery via envelope + ligand of choice
In the News
The Latest from Chimeron Bio
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
read more
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
300
300
Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio | Advancing Genetic Medicine
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
Chimeron Bio Welcomes Kevin Heyeck as New CEO
read more
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
300
300
Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio | Advancing Genetic Medicine
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
read more
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp
206
206
Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio | Advancing Genetic Medicine
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
Chimeron Bio Enters Into an Agreement with the NIAID, a Federal Agency, for Pre-clinical Assessment of its Self-Amplifying COVID-19 Vaccine
read more
https://www.chimeron.com/wp-content/uploads/2023/05/Covid-19-vaccine2.jpg
300
300
Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio | Advancing Genetic Medicine
https://www.chimeron.com/wp-content/uploads/2023/05/Covid-19-vaccine2.jpg